Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 5, 2001, Pages 834-839

  Steinhorn, Robin H ^a   Albert, George ^b   Swartz, Daniel D ^b   Russell, James A ^b   Levine, Carolyn R ^b   Davis, Jonathan M ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

Free radical scavengers; Lung; Newborn; Pulmonary artery

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; RECOMBINANT ENZYME;

ARTICLE; DRUG EFFICACY; DUCTUS ARTERIOSUS OBLITERATION; HEMODYNAMICS; LAMB; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0035447003     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.5.2010104     Document Type: Article

References (38)

1. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs
2. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb
3. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb
4. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth
5. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs
6. Effect of nitric oxide on survival and lung injury in newborn lambs with persistent pulmonary hypertension
7. Inhaled nitric oxide gas improves oxygenation in PPHN
8. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
9. Low dose nitric oxide therapy for persistent pulmonary hypertension of the newborn
10. Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia
11. Disruption of cyclic GMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension
12. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation
13. Design of airways and blood vessels considered as branching trees
14. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide
15. Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hypertension
16. Safety and pharmacokinetics of intratracheal recombinant human superoxide dismutase in premature infants with respiratory distress syndrome
17. The effect of hyperoxic exposure on antioxidant cells in neonatal and adult rats
18. Effect of oxygen on lung superoxide dismutase activities in premature baboons with bronchopulmonary dysplasia
19. Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: A role for superoxide
20. Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation
21. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation
22. Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs
23. Relaxant effects of carbon monoxide compared with nitric oxide in pulmonary and systemic vessels of newborn piglets
24. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome
25. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide
26. Superoxide dismutase and catalase do not affect the pulmonary hypertensive response to Group B streptococcus in the lamb
27. Superoxide anion production by rabbit thoracic aorta: Effect of endothelium derived nitric oxide
28. Superoxide released to high intraarteriolar pressure reduces nitric oxide-mediated shear stress and agonist induced dilations
29. Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO
30. A new pathway of nitric oxide/cyclic GMP signaling involving s-nitrosoglutathione
31. Intracellular uptake of recombinant superoxide dismutase after intracheal administration
32. Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase using a modified ultrasonic nebulizer
33. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia
34. The structural basis of persistent pulmonary hypertension of the newborn infant
35. Pulmonary endothelial nitric oxide production is developmentally regulated in the fetus and newborn
36. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period
37. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase gene expression is regulated during rat pulmonary development
38. Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension